News
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
3d
News-Medical.Net on MSNTirzepatide tops the charts for blood sugar and weight loss in type 2 diabetesA large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight ...
Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
2d
Best Life on MSNScientists Discover Another Major Weight-Loss Drug Side Effect—But This Time, It’s GoodResearchers say GLP-1 medicines might be able to help with migraines.
6d
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
Higher glycemia was associated with worse cognitive score outcomes among patients with short-duration type 2 diabetes at 4-year follow-up.
The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results